Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Freenome, Siemens Healthineers Partner to ID Blood-Based Breast Cancer Biomarkers
The companies aim to use multiomic and other types of data to identify blood-based biomarkers that can help in the early diagnosis of breast cancer.
Radiomics, OncoDNA Partner to ID Lung Cancer Biomarkers
The two Belgian firms will apply machine learning-based imaging analysis and genetic sequencing to identify biomarkers of NSCLC progression and therapy response.
Postsurgical ctDNA Analysis Predicts Adjuvant Chemotherapy Benefit in NSCLC
Research out of Geneseeq and the Chinese Academy of Medical Sciences shows the value of ctDNA analysis to guide treatment and predict disease recurrence.
Valted Seq Raises $10.5M Seed Funding
The firm will put the funding toward its HiF-Seq single-cell sequencing platform, which will be used to interrogate neurodegenerative disease samples.
Genialis Expands Partnership With Slovenia's BioLab
A €400,000, three-year grant from the Slovenian Research Agency will support new bioinformatics technologies for biomarker discovery.